Table 4 predicted prostate cancer detection tests performed nationally based on linear regression of tests performed in 2015–2019 compared to tests performed in 2020
From: The effect of COVID-19 on prostate cancer testing in Australia
Predicted tests in 2020 (95% Prediction Interval) | R2 of model | Tests performed in 2020 | Difference (% of predicted) | Significance | |
|---|---|---|---|---|---|
PSA tests | 698,036 (568,163–827,909) | 0.59 | 657,687 | − 40,349 (94) | P = 0.379 (t = 0.99) |
Prostate biopsies | 20,353 (10,811–29,896) | 0.29 | 20,463 | + 110 (100) | P = 0.973 (t = − 0.036) |